Impact of the combined application of Advanced-Platelet Rich Fibrin (A-PRF) and low-level laser therapy (LLLT) on healing, discomfort and quality of life in patients undergoing palatal subepithelial connective tissue graft removal.

Not Applicable

Recruiting

• Conditions: Platelet-Rich Fibrin; C07.465.714.258.447

• Registration Number: RBR-2h86wf5
• Lead Sponsor: nioeste - Universidade Estadual do Oeste do Paraná

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-03-04
• Last Update Posted: 2 April 2024
• Study Completion: 2025-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Age range from 18 to 50 years; both genders; must present tooth(s) with gingival recession that requires surgical treatment with a subepithelial connective tissue graft to be removed from the palate. All teeth in the dental arch must be healthy; with all sites presenting a probing depth of less than or equal to 3mm; with a bleeding rate of less than or equal to 5%; without gingival inflammation and free of carie

Exclusion Criteria

Smokers, pregnant and lactating patients, patients with a previous history of periodontal surgery, patients who have used antibiotic therapy in the last six months or who are using antibiotic therapy, steroidal or non-steroidal anti-inflammatory drugs at the time of the study, positive history of any systemic disorder that contraindicate the surgical procedure, teeth with root caries, non-carious cervical lesions or with any type of previous cervical restoration, extruded, rotated, proclined or mobile teeth, endodontic treatment or pulp pathology in the involved tooth and pathogenic occlusal interferences. Each patient's medical history will be obtained through anamnesis and all participants will undergo a clinical examination

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hope that there is an improvement in healing, discomfort and quality of life in patients undergoing the combined technique of Advanced platelet-rich fibrin (A-PRF) + Low level laser therapy (LLLT) in Subepithelial connective tissue graft (SCTG) donor sites compared to the isolated use of Advanced platelet-rich fibrin (A-PRF)

Secondary Outcome Measures

Name	Time	Method
Hope that the newly formed tissue in the donor area is compared to the preoperative thickness in the same location and that there is a reduction in postoperative complications when using Low level laser therapy (LLLT)